Aquestive Therapeutics Inc.
AQST | NASDAQ
$4.78
+$0.17 (+3.69%)
At close: Sep 21, 2026, 4:00 PM ET
$4.84
+$0.06 (+1.23%)
Pre-market:
Sep 22, 2026, 8:19 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 98.49M | 110.73M | 121.17M | 129.06M | 60.54M | 68.66M | 71.55M | 77.89M | 89.87M | 95.2M | 23.87M | 24.92M | 22.44M | 26.88M | 27.27M | 18.65M | 17.7M | 14.74M | 28.02M | 31.16M | 34.23M | 27.5M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 2M | 2M | 2M | n/a | 3M | 3M | 3M | n/a | n/a | 4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6M | n/a | n/a | n/a |
Other Long-Term Assets | 1.7M | 635K | 642K | 1.2M | 3.21M | 1.22M | 1.22M | 1.23M | 4.24M | 5.42M | 1.44M | 5.45M | 5.47M | 6.49M | 6.45M | 5.89M | 5.9M | 6.89M | 6.9M | 6.91M | 6.91M | 7.84M |
Receivables | 9.33M | 6.87M | 17.76M | 11.8M | 11.86M | 10.44M | 7.34M | 9.68M | 6M | 8.32M | 8.47M | 8.55M | 10.1M | 7.55M | 4.7M | 10.74M | 19.17M | 19.9M | 12.12M | 13.64M | 12.13M | 10.21M |
Inventory | 7.37M | 8.07M | 6.17M | 7.88M | 8.13M | 7.2M | 6.04M | 7.02M | 6.97M | 7.73M | 6.77M | 7.08M | 5.95M | 6.98M | 5.78M | 6.73M | 5.01M | 4.63M | 4.04M | 2.86M | 2.84M | 2.8M |
Other Current Assets | n/a | 4.52M | 4.17M | 2.93M | 1.2M | 2.87M | 3.29M | 1.97M | 1.18M | 2.12M | 1.85M | 1.91M | 1.3M | 2.29M | 2.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 118.49M | 130.18M | 149.27M | 151.67M | 81.72M | 89.17M | 88.22M | 96.57M | 104.01M | 113.38M | 40.97M | 42.46M | 39.79M | 43.71M | 39.89M | 38.09M | 43.51M | 42.59M | 47.26M | 50.21M | 51M | 44.44M |
Property-Plant & Equipment | 11.91M | 8.31M | 8.51M | 8.69M | 8.77M | 8.85M | 8.98M | 9.16M | 9.36M | 9.49M | 9.74M | 10.22M | 10.38M | 9.7M | 9.3M | 6.38M | 6.88M | 7.02M | 7.78M | 8.11M | 8.89M | 9.56M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.24M | 1.28M | 1.32M | 1.36M | 1.4M | 1.44M | 1.49M | 25K | 38K | 51K | 64K | 76K | 89K |
Total Long-Term Assets | 13.61M | 10.94M | 11.16M | 11.89M | 11.98M | 13.07M | 13.2M | 13.39M | 13.59M | 16.14M | 16.45M | 16.99M | 17.21M | 17.58M | 17.18M | 13.76M | 12.81M | 13.94M | 14.73M | 15.08M | 15.88M | 17.48M |
Total Assets | 132.1M | 141.13M | 160.43M | 163.56M | 93.7M | 102.23M | 101.42M | 109.96M | 117.61M | 129.52M | 57.42M | 59.45M | 56.99M | 61.29M | 57.07M | 51.85M | 56.31M | 56.53M | 61.99M | 65.29M | 66.88M | 61.92M |
Account Payables | 8.97M | 11.89M | 29.86M | 10.87M | 11.95M | 12.28M | 10.29M | 7.57M | 5.7M | 10.52M | 8.93M | 9.99M | 10.69M | 12.44M | 9.95M | 11.07M | 8.89M | 8.5M | 8.31M | 6.22M | 8.1M | 6.69M |
Deferred Revenue | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | 1.05M | 1.05M | 1.05M | 1.05M | 1.55M | 1.55M | 2.64M | 3.99M | 4.77M | 1.51M | 774K | 1.6M | 1.6M | 765K | 767K | 642K | 437K |
Short-Term Debt | n/a | 15.32M | 11.63M | 8.49M | 3.18M | 27K | 26K | 25K | 24K | 23K | 22K | 4.61M | 18.36M | 17.2M | 18.7M | 14.23M | 9.75M | 6.56M | 2.03M | 7.73M | 5.15M | 3.86M |
Other Current Liabilities | 1.08M | 1.38M | 1.32M | 1.43M | 4.89M | 3.28M | 1M | 4.46M | 3.67M | 2.64M | 5.12M | 3.82M | 3.8M | 3.55M | 7.54M | 6.85M | 5.37M | 3.33M | 7.19M | 6.44M | 5.82M | 5.56M |
Total Current Liabilities | 16.48M | 31.75M | 47.61M | 25.57M | 23.16M | 18.3M | 18.87M | 15.15M | 13.9M | 18.06M | 18.31M | 24.06M | 38.65M | 40.38M | 39.53M | 36.56M | 29.64M | 24.18M | 21.96M | 25.04M | 23.04M | 20.05M |
Long-Term Debt | 50.65M | 114.1M | 115.48M | 115.87M | 31.84M | 33.75M | 32.5M | 31.25M | 30.01M | 28.76M | 27.51M | 34.56M | 20.8M | 25.2M | 33.45M | 38.68M | 43.82M | 47.68M | 51.55M | 32.67M | 34.07M | 34.19M |
Other Long-Term Liabilities | 95.19M | 6.05M | 7.27M | 2.06M | 86.69M | 86.55M | 85.24M | 83.6M | 82.19M | 81.77M | 80.35M | 65.52M | 65.46M | 66.2M | 66.15M | 65.47M | 64.22M | 62.21M | 2.49M | 58.43M | 54.77M | 52.14M |
Total Long-Term Liabilities | 172.21M | 143.43M | 146.48M | 142.09M | 143.13M | 144.87M | 142.72M | 140.23M | 139.19M | 147.77M | 145.6M | 138.32M | 124.99M | 130.14M | 136.1M | 123.1M | 123.03M | 125.49M | 122.16M | 100.6M | 97.61M | 93.67M |
Total Liabilities | 188.69M | 175.18M | 194.09M | 167.67M | 166.29M | 163.16M | 161.58M | 155.38M | 153.08M | 165.82M | 163.91M | 162.38M | 163.65M | 170.52M | 175.62M | 159.66M | 152.67M | 149.67M | 144.13M | 125.64M | 120.64M | 113.72M |
Total Debt | 59M | 133.58M | 131.45M | 128.86M | 40.26M | 39.14M | 38M | 36.87M | 35.72M | 34.48M | 33.32M | 45.04M | 45.12M | 48.43M | 57.49M | 55.09M | 55.99M | 56.88M | 56.42M | 43.44M | 42.46M | 41.48M |
Book Value | -56.59M | -34.05M | -33.66M | -4.11M | -72.59M | -60.93M | -60.16M | -45.42M | -35.48M | -36.3M | -106.49M | -102.93M | -106.65M | -109.24M | -118.55M | -107.82M | -96.36M | -93.14M | -82.13M | -60.35M | -53.77M | -51.8M |
Book Value Per Share | -0.45 | -0.28 | -0.28 | -0.04 | -0.73 | -0.64 | -0.66 | -0.50 | -0.39 | -0.49 | -1.55 | -1.59 | -1.86 | -1.48 | -2.18 | -2.02 | -2.12 | -2.25 | -2.03 | -1.54 | -1.45 | -1.46 |
Common Stock | 126K | 124K | 122K | 121K | 99K | 99K | 91K | 91K | 91K | 90K | 69K | 67K | 62K | 56K | 55K | 54K | 53K | 41K | 41K | 40K | 39K | 36K |
Retained Earnings | -477.92M | -455.06M | -447M | -415.14M | -399.69M | -386.14M | -363.21M | -346.16M | -334.65M | -331.91M | -319.08M | -310.97M | -308.93M | -303.14M | -311.21M | -298.86M | -286.32M | -270.02M | -256.8M | -227.85M | -213.3M | -200.93M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -56.59M | -34.05M | -33.66M | -4.11M | -72.59M | -60.93M | -60.16M | -45.42M | -35.48M | -36.3M | -106.49M | -102.93M | -106.65M | -109.24M | -118.55M | -107.82M | -96.36M | -93.14M | -82.13M | -60.35M | -53.77M | -51.8M |
Total Investments | n/a | 2M | 2M | 2M | n/a | 3M | 3M | 3M | n/a | n/a | 4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AQST